Clinical Trial Update: An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination [Phase 3]

View source ↗

Summary

An open-label, long-term Phase 3 study of a telmisartan/amlodipine fixed-dose combination for hypertension was completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan/amlodipine fixed-dose combination (telmisartan/amlodipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-03-03